These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23612121)

  • 1. To the editor - Inside-out insulation failure of a defibrillator lead with abrasion resistant-coating.
    James B; Klehn R; Jenney C; Fischer A
    Heart Rhythm; 2013 Jun; 10(6):e72-3. PubMed ID: 23612121
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the editor - Inside-out insulation failure of a defibrillator lead with abrasion-resistant coating.
    Swerdlow CD; Kass RM; Khoynezhad A
    Heart Rhythm; 2013 Jun; 10(6):e73. PubMed ID: 23623800
    [No Abstract]   [Full Text] [Related]  

  • 3. Inside-out insulation failure of a defibrillator lead with abrasion-resistant coating.
    Swerdlow CD; Kass RM; Khoynezhad A; Tang S
    Heart Rhythm; 2013 Jul; 10(7):1063-6. PubMed ID: 23524322
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of a defibrillator lead: how durable is Durata?
    Brinker J
    Heart Rhythm; 2013 Jul; 10(7):1067-8. PubMed ID: 23727059
    [No Abstract]   [Full Text] [Related]  

  • 5. User-reported abrasion-related lead failure is more common with durata compared to other implantable cardiac defibrillator leads.
    Shah AD; Hirsh DS; Langberg JJ
    Heart Rhythm; 2015 Dec; 12(12):2376-80. PubMed ID: 26165944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect.
    Hauser RG; McGriff D; Retel LK
    Heart Rhythm; 2012 May; 9(5):742-9. PubMed ID: 22209723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of asymptomatic and electrically undetectable intracardiac inside-out abrasion in silicon-coated Riata® and Riata® ST implantable cardioverter-defibrillator leads.
    Schmutz M; Delacrétaz E; Schwick N; Roten L; Fuhrer J; Boesch C; Tanner H
    Int J Cardiol; 2013 Jul; 167(1):254-7. PubMed ID: 22236515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Implantable Cardioverter-Defibrillator Shocks After Left Ventricular Assist Device Implantation.
    Pfeffer TJ; König T; Duncker D; Michalski R; Hohmann S; Oswald H; Schmitto JD; Veltmann C
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27793958
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads.
    Forleo GB; Di Biase L; Panattoni G; Politano A; Magliano G; Santini L; Natale A; Romeo F
    Europace; 2014 Feb; 16(2):265-70. PubMed ID: 24042736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the mechanism of failure of the Riata lead under advisory.
    Parkash R; Tung S; Champagne J; Healey JS; Thibault B; Cameron D; Tang A; Connors S; Beardsall M; Mangat I; Ayala-Paredes F; Toal S; Exner D; Yee R; Krahn AD
    Heart Rhythm; 2015 Mar; 12(3):574-579. PubMed ID: 25485777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of heart failure decompensation using intrathoracic impedance monitoring by a triple-chamber implantable defibrillator.
    Lüthje L; Drescher T; Zenker D; Vollmann D
    Heart Rhythm; 2005 Sep; 2(9):997-9. PubMed ID: 16171758
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable Cardiac Defibrillator Lead Failure and Management.
    Swerdlow CD; Kalahasty G; Ellenbogen KA
    J Am Coll Cardiol; 2016 Mar; 67(11):1358-68. PubMed ID: 26988958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of indications for cardiac resynchronisation therapy in the implantable cardioverter defibrillator population.
    Paisey JR; Yue AM; Moore R; Betts TR; Roberts PR; Morgan JM
    Int J Cardiol; 2005 Mar; 99(2):187-90. PubMed ID: 15749173
    [No Abstract]   [Full Text] [Related]  

  • 14. Repetitive pacemaker spike during the vulnerable period in a cardiac resynchronization therapy defibrillator.
    Arias MA; Pachón M; Puchol A; Castellanos E
    Heart Rhythm; 2011 Jan; 8(1):148-51. PubMed ID: 20708712
    [No Abstract]   [Full Text] [Related]  

  • 15. Inappropriate shock from nonphysiologic noise during implantation of a Boston Scientific COGNIS N119 biventricular implantable cardioverter-defibrillator (CRT-D).
    McManus DD; Rosenthal LS; Robotis DA
    Heart Rhythm; 2009 Jul; 6(7):1066-8. PubMed ID: 19560093
    [No Abstract]   [Full Text] [Related]  

  • 16. Sudden and Fatal Malfunction of a Durata Defibrillator Lead due to External Insulation Failure.
    Shah AD; Hirsh DS; Langberg JJ
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):101-4. PubMed ID: 26293817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using left-ventricular-only pacing to eliminate T-wave oversensing in a biventricular implantable cardiac defibrillator.
    Khoo C; Bennett M; Chakrabarti S; LeMaitre J; Tung SK
    Can J Cardiol; 2013 Feb; 29(2):254.e5-7. PubMed ID: 22902157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual adverse consequence of reverse ventricular remodelling following cardiac resynchronization therapy.
    Chia PL; Subbiah RN; Kuchar D; Walker B
    Europace; 2012 Aug; 14(8):1216-7. PubMed ID: 22266053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate shock delivery and biventricular pacing cardiac defibrillators.
    Liu BC; Villareal RP; Hariharan R; Rasekh A; Massumi A
    Tex Heart Inst J; 2003; 30(1):45-9. PubMed ID: 12638671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy].
    van Gelder IC; Smit MD; Nieuwland W; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2238-44. PubMed ID: 17076357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.